MEDICINES CO /DE Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-08-02: Reporting owner Rodin Stephen M; Form 4; Security Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-01-16: Reporting owner SBLENDORIO GLENN; Form 4; Security Common stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-01-16: Reporting owner O'Connor William Bernard; Form 4; Security Common stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-08-02 | Rodin Stephen M Officer (EVP and General Counsel) | 4 | Common Stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $8.38 exercise price | 2019-08-06 | |
| 2013-01-16 | SBLENDORIO GLENN Director, Officer (President & CFO) | 4 | Common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 50,000 owned after | $20.11 exercise price | 2013-01-17 | |
| 2013-01-16 | O'Connor William Bernard Officer (Chief Accounting Officer) | 4 | Common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,302 6,198 owned after | $7.31 exercise price | 2013-01-17 |